Send us A Message
Ask Us A Question.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
.svg){kind=icon}
Contact
285 Fulton St, Suite 8500,
New York, NY 10007
New York, NY 10007
A Team Purpose-Built To Vet Life Sciences Commercial Risk.
SVRN was founded to create new pathways to invest in the value of biomedical innovation and to empower scientific innovations to reach more patients.
Built by Industry Experts
Our team is led by experienced operators and experts who have worked across the biopharma and medtech sectors.
We diligence and underwrite risks associated with commercial launches, market expansion, and lifecycle investments.
We have extensive experience vetting the essential elements of commercial success, including go-to-market strategy, competitive dynamics, reimbursement risks, and policy evolution.
The Commercialization Capital Gap
Find clear, straightforward answers to the most common questions about our approach.
Why is there a financing gap in biomedical commercialization?
Where is the funding gap most persistent?
When is revenue financing most attractive?
Why revenue financing vs. equity and debt?
What is synthetic royalty financing?
